|Bid||58.20 x 1100|
|Ask||58.42 x 900|
|Day's Range||58.20 - 58.85|
|52 Week Range||46.05 - 69.10|
|Beta (5Y Monthly)||0.91|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 05, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||8.00 (13.70%)|
|Ex-Dividend Date||May 28, 2021|
|1y Target Est||N/A|
French oil giant Total cut its stake in natural-gas firm Tellurian. Advent International cut dow its stake in clinical-trial services firm Syneos Health.
Forward-looking statements may be identified by words such as expects, anticipates, intends, plans, believes, seeks, estimates, will, or words of similar meaning and include, but are not limited to statements about the expected future business and financial performance of Icahn Enterprises L.P. and its subsidiaries. Actual events, results, and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties, and other factors that are discussed in our filings with the Securities and Exchange Commission, including economic, competitive, legal, and other factors including the severity, magnitude, and duration of the COVID-19 pandemic.
First quarter net income attributable to Icahn Enterprises of $162 million, or $0.65 per depositary unitBoard approves quarterly distribution of $2.00 per depositary unit SUNNY ISLES BEACH, Fla., May 07, 2021 (GLOBE NEWSWIRE) -- Icahn Enterprises L.P. (Nasdaq:IEP) is reporting first quarter 2021 revenues of $3.4 billion and net income attributable to Icahn Enterprises of $162 million, or $0.65 per depositary unit. For the three months ended March 31, 2020, revenues were $(60) million and net loss attributable to Icahn Enterprises was $1.4 billion, or a loss of $6.34 per depositary unit. For the three months ended March 31, 2021, Adjusted EBITDA attributable to Icahn Enterprises was $435 million compared to $(1.3) billion for the three months ended March 31, 2020. For the three months ended March 31, 2021, Adjusted EBIT attributable to Icahn Enterprises was $342 million compared to $(1.4) billion for the three months ended March 31, 2020. For the quarter ended March 31, 2021, indicative net asset value increased by $668 million to $4.22 billion compared to $3.55 billion as of December 31, 2020. On May 5, 2021, the Board of Directors of the general partner of Icahn Enterprises declared a quarterly distribution in the amount of $2.00 per depositary unit, which will be paid on or about June 30, 2021 to depositary unitholders of record at the close of business on June 1, 2021. Depositary unitholders will have until June 18, 2021 to make a timely election to receive either cash or additional depositary units. If a unitholder does not make a timely election, it will automatically be deemed to have elected to receive the distribution in additional depositary units. Depositary unitholders who elect to receive (or who are deemed to have elected to receive) additional depositary units will receive units valued at the volume weighted average trading price of the units during the 5 consecutive trading days ending June 25, 2021. Icahn Enterprises will make a cash payment in lieu of issuing fractional depositary units to any unitholders electing to receive (or who are deemed to have elected to receive) depositary units. Icahn Enterprises L.P., a master limited partnership, is a diversified holding company engaged in eight primary business segments: Investment, Energy, Automotive, Food Packaging, Metals, Real Estate, Home Fashion and Pharma. Caution Concerning Forward-Looking Statements Results for any interim period are not necessarily indicative of results for any full fiscal period. This release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, many of which are beyond our ability to control or predict. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Icahn Enterprises L.P. and its subsidiaries. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors, including risks related to economic downturns, substantial competition and rising operating costs; risks related to the severity, magnitude and duration of the COVID-19 pandemic and its impact on the global economy, financial markets and industries in which our subsidiaries operate; risks related to our investment activities, including the nature of the investments made by the private funds in which we invest, declines in the fair value of our investments as a result of the COVID-19 pandemic, losses in the private funds and loss of key employees; risks related to our ability to continue to conduct our activities in a manner so as to not be deemed an investment company under the Investment Company Act of 1940, as amended; risks related to our energy business, including the volatility and availability of crude oil, declines in global demand for crude oil, refined products and liquid transportation fuels as a result of the COVID-19 pandemic, other feed stocks and refined products, unfavorable refining margin (crack spread), interrupted access to pipelines, significant fluctuations in nitrogen fertilizer demand in the agricultural industry and seasonality of results; risks related to our automotive activities and exposure to adverse conditions in the automotive industry, including as a result of the COVID-19 pandemic; risks related to our food packaging activities, including competition from better capitalized competitors, inability of suppliers to timely deliver raw materials, and the failure to effectively respond to industry changes in casings technology; risks related to our scrap metals activities, including potential environmental exposure; risks related to our real estate activities, including the extent of any tenant bankruptcies and insolvencies; risks related to our home fashion operations, including changes in the availability and price of raw materials, and changes in transportation costs and delivery times; and other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission. Past performance in our Investment segment is not indicative of future performance. We undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(UNAUDITED) Three Months Ended March 31, 2021 2020 (In millions, except per unit amounts)Revenues: Net sales$2,218 $1,860 Other revenues from operations 152 161 Net gain (loss) from investment activities 1,006 (2,128)Interest and dividend income 26 64 Other loss, net (18) (17) 3,384 (60)Expenses: Cost of goods sold 2,139 1,810 Other expenses from operations 118 135 Selling, general and administrative 316 308 Restructuring, net — 2 Interest expense 195 171 2,768 2,426 Income (loss) before income tax (expense) benefit 616 (2,486)Income tax (expense) benefit (17) 180 Net income (loss) 599 (2,306)Less: net income (loss) attributable to non-controlling interests 437 (922)Net income (loss) attributable to Icahn Enterprises$162 $(1,384) Net income (loss) attributable to Icahn Enterprises allocated to: Limited partners$159 $(1,356)General partner 3 (28) $162 $(1,384) Basic income (loss) per LP unit$0.66 $(6.34)Basic weighted average LP units outstanding 242 214 Diluted income (loss) per LP unit$0.65 $(6.34)Diluted weighted average LP units outstanding 245 214 Cash distributions declared per LP unit$2.00 $2.00 CONDENSED CONSOLIDATED BALANCE SHEETS(UNAUDITED) March 31, December 31, 2021 2020 (In millions)ASSETS Cash and cash equivalents$1,942 $1,679 Cash held at consolidated affiliated partnerships and restricted cash 1,134 1,612 Investments 11,480 8,913 Due from brokers 4,234 3,437 Accounts receivable, net 572 501 Inventories, net 1,559 1,580 Property, plant and equipment, net 4,231 4,228 Unrealized gain on derivative contracts 855 785 Goodwill 294 294 Intangible assets, net 643 660 Other assets 1,353 1,296 Total Assets$28,297 $24,985 LIABILITIES AND EQUITY Accounts payable$851 $738 Accrued expenses and other liabilities 2,303 1,584 Deferred tax liabilities 549 568 Unrealized loss on derivative contracts 584 639 Securities sold, not yet purchased, at fair value 4,863 2,521 Due to brokers 1,509 1,618 Debt 8,056 8,059 Total liabilities 18,715 15,727 Equity: Limited partners 4,086 4,236 General partner (856) (853)Equity attributable to Icahn Enterprises 3,230 3,383 Equity attributable to non-controlling interests 6,352 5,875 Total equity 9,582 9,258 Total Liabilities and Equity$28,297 $24,985 Use of Non-GAAP Financial Measures The Company uses certain non-GAAP financial measures in evaluating its performance. These include non-GAAP EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT. EBITDA represents earnings from continuing operations before interest expense, income tax (benefit) expense and depreciation and amortization. EBIT represents earnings from continuing operations before interest expense and income tax (benefit) expense. We define Adjusted EBITDA and Adjusted EBIT as EBITDA and EBIT, respectively, excluding certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt, major scheduled turnaround expenses, certain tax settlements and certain other non-operational charges. We present EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT on a consolidated basis and on a basis attributable to Icahn Enterprises net of the effects of non-controlling interests. We conduct substantially all of our operations through subsidiaries. The operating results of our subsidiaries may not be sufficient to make distributions to us. In addition, our subsidiaries are not obligated to make funds available to us for payment of our indebtedness, payment of distributions on our depositary units or otherwise, and distributions and intercompany transfers from our subsidiaries to us may be restricted by applicable law or covenants contained in debt agreements and other agreements to which these subsidiaries currently may be subject or into which they may enter into in the future. The terms of any borrowings of our subsidiaries or other entities in which we own equity may restrict dividends, distributions or loans to us. We believe that providing EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT to investors has economic substance as these measures provide important supplemental information of our performance to investors and permits investors and management to evaluate the core operating performance of our business without regard to interest, taxes and depreciation and amortization and certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt, major scheduled turnaround expenses, certain tax settlements and certain other non-operational charges. Additionally, we believe this information is frequently used by securities analysts, investors and other interested parties in the evaluation of companies that have issued debt. Management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results, as well as in planning, forecasting and analyzing future periods. Adjusting earnings for these charges allows investors to evaluate our performance from period to period, as well as our peers, without the effects of certain items that may vary depending on accounting methods and the book value of assets. Additionally, EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT present meaningful measures of performance exclusive of our capital structure and the method by which assets were acquired and financed. EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under generally accepted accounting principles in the United States, or U.S. GAAP. For example, EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT: do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments;do not reflect changes in, or cash requirements for, our working capital needs; anddo not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on our debt. Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. Other companies in the industries in which we operate may calculate EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT differently than we do, limiting their usefulness as comparative measures. In addition, EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations. EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT are not measurements of our financial performance under U.S. GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with U.S. GAAP or as alternatives to cash flow from operating activities as a measure of our liquidity. Given these limitations, we rely primarily on our U.S. GAAP results and use EBITDA, Adjusted EBITDA, EBIT and Adjusted EBIT only as a supplemental measure of our financial performance. Use of Indicative Net Asset Value Data The Company uses indicative net asset value as an additional method for considering the value of the Company’s assets, and we believe that this information can be helpful to investors. Please note, however, that the indicative net asset value does not represent the market price at which the depositary units trade. Accordingly, data regarding indicative net asset value is of limited use and should not be considered in isolation. The Company's depositary units are not redeemable, which means that investors have no right or ability to obtain from the Company the indicative net asset value of units that they own. Units may be bought and sold on The Nasdaq Global Select Market at prevailing market prices. Those prices may be higher or lower than the indicative net asset value of the depositary units as calculated by management. See below for more information on how we calculate the Company’s indicative net asset value. March 31, December 31, 2021 2020 (In millions)(Unaudited)Market-valued Subsidiaries and Investments: Holding Company interest in Investment Funds(1)$4,675 $4,283 CVR Energy(2) 1,366 1,061 Tenneco(2) 136 292 Total market-valued subsidiaries and investments$ 6,177 $ 5,636 Other Subsidiaries: Viskase(3)$293 $285 Real Estate Holdings(1) 443 440 PSC Metals(1) 133 128 WestPoint Home(1) 137 141 Vivus(1) 270 262 Icahn Automotive Group(1) 1,558 1,554 Total other subsidiaries$ 2,834 $ 2,810 Add: Other Holding Company net assets(4) (124) (12)Indicative Gross Asset Value$ 8,887 $ 8,434 Add: Holding Company cash and cash equivalents(5) 1,134 925 Less: Holding Company debt(5) (5,805) (5,811)Indicative Net Asset Value$ 4,216 $ 3,548 Indicative net asset value does not purport to reflect a valuation of IEP. The calculated Indicative net asset value does not include any value for our Investment Segment other than the fair market value of our investment in the Investment Funds. A valuation is a subjective exercise and Indicative net asset value does not necessarily consider all elements or consider in the adequate proportion the elements that could affect the valuation of IEP. Investors may reasonably differ on what such elements are and their impact on IEP. No representation or assurance, expressed or implied is made as to the accuracy and correctness of indicative net asset value as of these dates or with respect to any future indicative or prospective results which may vary. (1)Represents equity attributable to us as of each respective date.(2)Based on closing share price on each date (or if such date was not a trading day, the immediately preceding trading day) and the number of shares owned by the Holding Company as of each respective date.(3)Amounts based on market comparables due to lack of material trading volume, valued at 9.0x Adjusted EBITDA for the twelve months ended March 31, 2021 and December 31, 2020.(4)Holding Company’s balance as of each respective date. For March 31, 2021, the distribution payable was adjusted to $27 million, which represents the actual distribution paid subsequent to March 31, 2021.(5)Holding Company’s balance as of each respective date. Three Months Ended March 31, 2021 2020 (In millions)(Unaudited)Adjusted EBITDA Net income (loss)$599 ($2,306)Interest expense, net 194 162 Income tax expense (benefit) 17 (180)Depreciation, depletion and amortization 127 121 EBITDA before non-controlling interests 937 (2,203)Restructuring costs - 2 Gain on disposition of assets, net - (1)Other 15 39 Adjusted EBITDA before non-controlling interests$952 ($2,163) Adjusted EBITDA attributable to IEP Net income (loss)$162 ($1,384)Interest expense, net 136 126 Income tax expense (benefit) 30 (167)Depreciation, depletion and amortization 93 85 EBITDA attributable to IEP 421 (1,340)Restructuring costs - 2 Gain on disposition of assets, net - (1)Other 14 35 Adjusted EBITDA attributable to IEP$435 ($1,304) Three Months Ended March 31, 2021 2020 (In millions)(Unaudited)Adjusted EBIT Net income (loss)$599 ($2,306)Interest expense, net 194 162 Income tax expense (benefit) 17 (180)EBIT before non-controlling interests 810 (2,324)Restructuring costs - 2 Gain on disposition of assets, net - (1)Other 15 39 Adjusted EBIT before non-controlling interests$825 ($2,284) Adjusted EBIT attributable to IEP Net income (loss)$162 ($1,384)Interest expense, net 136 126 Income tax expense (benefit) 30 (167)EBIT attributable to IEP 328 (1,425)Restructuring costs - 2 Gain on disposition of assets, net - (1)Other 14 35 Adjusted EBIT attributable to IEP$342 ($1,389) Investor Contacts:SungHwan Cho, Chief Financial Officer(305) 422-4000